Update on NuvaRing® Litigation Status

Posted on July 23, 2009 by Kevin M. Hart
no picture

NuvaRing® is marketed as a once-a-month, combined contraceptive vaginal ring that provides month-long birth control.   It is sold in the United States by Organon USA Inc., a New Jersey corporation with its principal place of business in Roseland, New Jersey, and Organon International, Inc., headquartered in the Netherlands. Its parent company, Schering-Plough Corp., is located in Kenilworth, New Jersey.  Complaints have alleged that hormone levels in NuvaRing® have resulted in death, the breakdown of tissue and organs, amputation, heart attacks, ischemic strokes, and deep vein thrombosis. 

 

Courts in the United States have consolidated NuvaRing® claims in two locations:  1) New Jersey Superior Court, Law Division, Civil Part, Bergen County Vicinage; and 2) the United States District Court for the Eastern District of Missouri.  As of July 1, 2009, there have been 79 cases filed in new Jersey Superior Court and more than one hundred in the Eastern District of Missouri.
 

Tags:
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.njlawblog.com/admin/trackback/146761
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.